Mazen Haddad

Mazen Haddad appears in our data through filings on Elixxer Ltd. shares, published by SEDI. Over a trading history stretching from 4 September 2020 to 15 April 2021, the count stands at 10 filings.

In open-market terms, that means 1 purchase worth €6,425 on one side and 9 sales worth €13k on the other. Sales outweigh purchases by €6,836. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2021: no purchases and 9 sales on the market.

Most recently, on 15 April 2021, the filings show an open-market sale worth €466 in Elixxer Ltd. The last purchase on record was published on 4 September 2020, which is 2,244 days ago. The median gap between a trade and its publication by SEDI is 3 days. The shorter that gap, the sooner other investors can see what insiders have done. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEDI disclosures alone and does not predict where the share price will go.